Recent studies have further found that during CAR T-cell therapy, certain solid tumors respond to tumor necrosis factor secreted by CAR T-cells, which in turn promotes tumor cells to secrete small sEVs carrying tumor antigens. The gene discussed is TNF; the disease is neoplasm.